Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 273 M292 M308 M315 M302 M 1.22 B Research & development 69 M69 M72 M59 M41 M 241 M Operating income 609 M783 M719 M707 M904 M 3.11 B Non-Operating Income, Total -3 M-49 M21 M-7 M-6 M -41 M Interest expense, net of interest capitalized 174 M194 M187 M191 M188 M 760 M Non-Operating Income, excl. Interest Expenses -176 M-221 M-177 M-195 M-191 M -784 M Unusual income/expense -1 M-22 M11 M-3 M-3 M -17 M Pretax income 471 M609 M582 M551 M748 M 2.49 B Equity in earnings ————— — Taxes 63 M90 M91 M103 M107 M 391 M Non-controlling/minority interest 56 M58 M72 M53 M74 M 257 M After tax other income/expense ————— — Net income before discontinued operations 352 M461 M419 M395 M567 M 1.84 B Discontinued operations ————— — Net income 352 M461 M419 M395 M567 M 1.84 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 352 M461 M419 M395 M567 M 1.84 B Basic earnings per share (Basic EPS) 0.490.660.610.590.85 2.71 Diluted earnings per share (Diluted EPS) 0.490.660.610.580.85 2.7 Average basic shares outstanding 712 M695 M682 M691 M669 M — Diluted shares outstanding 713 M696 M685 M693 M671 M — EBITDA 640 M835 M791 M799 M919 M 3.34 B EBIT 609 M783 M719 M707 M904 M 3.11 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 31 M52 M72 M92 M15 M 231 M